Could a simple meal change ease stomach troubles for kids on tumor drug?
NCT ID NCT05101148
Summary
This study is testing whether taking the drug selumetinib with a low-fat meal is easier on the stomach than taking it on an empty stomach for teenagers with neurofibromatosis type 1 (NF1) and inoperable tumors. Researchers want to see if eating first reduces common side effects like nausea and diarrhea without making the drug less effective. The goal is to find the best way to take this already-approved medication to improve comfort and adherence.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS TYPE 1 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Rochester, Minnesota, 55905, United States
-
Research Site
Akron, Ohio, 44308, United States
-
Research Site
Bydgoszcz, 85-094, Poland
-
Research Site
Gdansk, 80-952, Poland
-
Research Site
Warsaw, 02-091, Poland
-
Research Site
Moscow, 119620, Russia
-
Research Site
Moscow, 125412, Russia
-
Research Site
Barcelona, 08950, Spain
-
Research Site
Madrid, 28009, Spain
Conditions
Explore the condition pages connected to this study.